And Then There Were Two: FDA Approves Zelsuvmi for Molluscum Contagiosum
The U.S. Food and Drug Administration (FDA) has approved Zelsuvmi (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum in adults and children one year of age and older. Zelsuvmi is expected to be commercially available during the second half of 2024, according to Ligand Pharmaceuticals. Zelsuvmi is the first novel drug for the treatment of molluscum infections […]